Original articleNew insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides☆
-
Add time:08/18/2019 Source:sciencedirect.com
A series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamide and furamide analogues were investigated in radioligand binding studies at adenosine receptor subtypes with an aim to obtain potent and selective adenosine receptor ligands. Benzamide and furamide linked to thiazole was found to be crucial for high adenosine receptor affinity. The most potent compound indentified in this study was 5d with low nanomolar affinity for all four adenosine receptor subtypes. Compounds 5a and 5g showed moderate selectivity for A2A adenosine receptors. Molecular docking versus all four human adenosine receptors combined with membrane molecular dynamics studies were performed to rationalise the peculiar selectivity profile of 5d antagonist.
We also recommend Trading Suppliers and Manufacturers of 3-(CHLOROMETHYL)BENZAMIDE (cas 135654-16-9). Pls Click Website Link as below: cas 135654-16-9 suppliers
Prev:Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus
Next:Structure of malolactomycins A and B, novel 40-membered macrolide antibiotics) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus08/17/2019
- Research paperDiscovery of novel 4-(2-pyrimidinylamino)benzamide derivatives as highly potent and orally available hedgehog signaling pathway inhibitors08/16/2019
- Research paperDesign, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators08/15/2019
- Research paper1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase08/14/2019


